AQST vs MSFT: Which Stock is Better?
Side-by-side comparison of Aquestive Therapeutics Inc and Microsoft Corp in 2026
AQST
Aquestive Therapeutics Inc
$4.27
MSFT
Microsoft Corp
$404.14
Key Metrics Comparison
| Metric | AQST | MSFT | Winner |
|---|---|---|---|
| Market Cap | $512.41M | N/A | AQST |
| P/E Ratio | N/A | 25.38 | MSFT |
| EPS (TTM) | $N/A | $15.99 | MSFT |
| Revenue Growth | 0.1% | 0.2% | MSFT |
| Gross Margin | 58.3% | 68.6% | MSFT |
Analyze AQST
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AQST or MSFT a better investment?
Comparing AQST and MSFT: Aquestive Therapeutics Inc has a market cap of $512.41M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AQST and MSFT?
AQST (Aquestive Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AQST or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AQST or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.1% for AQST.
Which company is more profitable: AQST or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 58.3% for AQST.
Which is the larger company: AQST or MSFT?
Aquestive Therapeutics Inc (AQST) is larger with a market cap of $512.41M compared to N/A for MSFT.
Should I buy AQST or MSFT in 2026?
Both AQST and MSFT have investment merit. AQST trades at $4.27 while MSFT trades at $404.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AQST and MSFT stock?
Key differences: Market Cap ($512.41M vs N/A), P/E Ratio (N/A vs 25.4x), Revenue Growth (0.1% vs 0.2%), Gross Margin (58.3% vs 68.6%).